Ryo Kurita
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Genome-wide analysis of pseudogenes reveals HBBP1's human-specific essentiality in erythropoiesis and implication in β-thalassemia.
Journal: Developmental cell
Published: June 09, 2025
CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.
Journal: Stem cell research & therapy
Published: April 23, 2025
Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification.
Journal: Haematologica
Published: December 19, 2024
A genome-wide screen identifies genes required for erythroid differentiation.
Journal: Nature communications
Published: July 03, 2024
Establishment of a novel human basophil cell line for functional analysis and in vitro allergy testing.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: June 03, 2024
Erratum to: Comparing the two leading erythroid lines BEL-A and HUDEP-2.
Journal: Haematologica
Published: January 01, 2024
Efficient repair of human genetic defect by CRISPR/Cas9-mediated interlocus gene conversion.
Journal: Life medicine
Published: July 28, 2023
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors.
Journal: Molecular therapy. Nucleic acids
Published: April 28, 2023
Recombinant Cas9 protein production in an endotoxin-free system and evaluation with editing the BCL11A gene in human cells.
Journal: Protein expression and purification
Published: April 20, 2023
Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemia.
Journal: Nature communications
Published: February 01, 2023
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis.
Journal: Frontiers in genome editing
Published: January 10, 2023
Irradiation is not sufficient to eradicate residual immortalized erythroid cells in in vitro-generated red blood cell products.
Journal: Transfusion
Published: January 10, 2023
Last Updated: 09/26/2026